Mavatrep is primarily used in the development of treatments for chronic pain conditions. It functions as a TRPV1 antagonist, targeting the TRPV1 receptor involved in pain sensation and inflammation. This makes it a potential candidate for managing neuropathic pain, osteoarthritis, and other pain-related disorders. Research is ongoing to explore its efficacy and safety in clinical settings, with the aim of providing an alternative to traditional pain management therapies. Its application could offer relief to patients who do not respond well to conventional treatments.